Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.670
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Spero Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 66.8 | 47.98 | 103.78 | 53.51 | 18.26 | Upgrade
|
| Revenue Growth (YoY) | 39.24% | -53.77% | 93.95% | 193.10% | 95.67% | Upgrade
|
| Cost of Revenue | 38.47 | 96.76 | 51.44 | 47.59 | 64.53 | Upgrade
|
| Gross Profit | 28.34 | -48.78 | 52.34 | 5.92 | -46.27 | Upgrade
|
| Selling, General & Admin | 21.18 | 23.7 | 25.55 | 36.48 | 41.7 | Upgrade
|
| Operating Expenses | 21.18 | 23.7 | 25.55 | 36.48 | 41.7 | Upgrade
|
| Operating Income | 7.16 | -72.48 | 26.79 | -30.57 | -87.97 | Upgrade
|
| Interest Expense | - | - | - | -2.61 | -1.94 | Upgrade
|
| Interest & Investment Income | 2.51 | 4.74 | 3.94 | 1.11 | 0.35 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.06 | -0.01 | 0.86 | -0.19 | Upgrade
|
| EBT Excluding Unusual Items | 9.68 | -67.69 | 30.71 | -31.2 | -89.76 | Upgrade
|
| Merger & Restructuring Charges | -0.26 | -0.88 | - | -11.63 | - | Upgrade
|
| Asset Writedown | -0.59 | - | -5.31 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -3.58 | - | Upgrade
|
| Pretax Income | 8.83 | -68.57 | 25.4 | -46.42 | -89.76 | Upgrade
|
| Income Tax Expense | 0.26 | - | 2.6 | - | - | Upgrade
|
| Earnings From Continuing Operations | 8.57 | -68.57 | 22.81 | -46.42 | -89.76 | Upgrade
|
| Net Income | 8.57 | -68.57 | 22.81 | -46.42 | -89.76 | Upgrade
|
| Net Income to Common | 8.57 | -68.57 | 22.81 | -46.42 | -89.76 | Upgrade
|
| Shares Outstanding (Basic) | 56 | 54 | 53 | 38 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 59 | 54 | 53 | 38 | 31 | Upgrade
|
| Shares Change (YoY) | 9.25% | 1.98% | 40.98% | 21.65% | 38.01% | Upgrade
|
| EPS (Basic) | 0.15 | -1.27 | 0.43 | -1.23 | -2.91 | Upgrade
|
| EPS (Diluted) | 0.15 | -1.27 | 0.43 | -1.23 | -2.91 | Upgrade
|
| Free Cash Flow | -12.62 | -23.44 | -33 | -7.73 | -64.35 | Upgrade
|
| Free Cash Flow Per Share | -0.21 | -0.43 | -0.62 | -0.21 | -2.08 | Upgrade
|
| Gross Margin | 42.42% | -101.67% | 50.43% | 11.06% | -253.45% | Upgrade
|
| Operating Margin | 10.72% | -151.08% | 25.81% | -57.13% | -481.87% | Upgrade
|
| Profit Margin | 12.83% | -142.91% | 21.98% | -86.74% | -491.65% | Upgrade
|
| Free Cash Flow Margin | -18.90% | -48.86% | -31.79% | -14.45% | -352.47% | Upgrade
|
| EBITDA | 7.16 | -72.48 | 27.15 | -29.7 | -87.33 | Upgrade
|
| EBITDA Margin | 10.72% | -151.08% | 26.16% | -55.50% | - | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0.37 | 0.87 | 0.65 | Upgrade
|
| EBIT | 7.16 | -72.48 | 26.79 | -30.57 | -87.97 | Upgrade
|
| EBIT Margin | 10.72% | -151.08% | 25.81% | -57.13% | - | Upgrade
|
| Effective Tax Rate | 2.96% | - | 10.23% | - | - | Upgrade
|
| Revenue as Reported | 66.8 | 47.98 | 103.78 | 53.51 | 18.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.